BJ
CLDX icon

BlackRock Japan’s Celldex Therapeutics CLDX Stock Holding History

BlackRock Japan’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-16
Closed -$1K – 1430
2016
Q1 		$1K Sell
16
-60
-79% -$6.75K ﹤0.01% 1419
2015
Q4 		$18K Sell
76
-17
-18% -$3.71K ﹤0.01% 1175
2015
Q3 		$15K Buy
93
+17
+22% +$4.81K ﹤0.01% 1127
2015
Q2 		$29K Buy
76
+23
+43% +$9.13K ﹤0.01% 1141
2015
Q1 		$22K Buy
53
+29
+121% +$10.4K ﹤0.01% 1176
2014
Q4 		$7K Buy
+24
New +$5.97K ﹤0.01% 1288
2014
Q3 		– Sell
-8
Closed -$2K – 1258
2014
Q2 		$2K Sell
8
-133
-94% -$30K ﹤0.01% 1249
2014
Q1 		$37K Buy
+141
New +$54K ﹤0.01% 1200

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

BlackRock Japan's CLDX Position: Q2 2016 in Review

BlackRock Japan sold out of Celldex Therapeutics (CLDX) in Q2 2016, closing a stake of 16 shares — an estimated $1K sold.

BlackRock Japan first reported a position in CLDX in Q1 2014 and held it in 8 quarters. The position peaked at $37K in Q1 2014. 141 funds tracked by Wall St. Rank hold CLDX as of Q2 2016.

  • BlackRock Japan reported no remaining Celldex Therapeutics position as of Q2 2016 after selling out during the quarter.
  • BlackRock Japan sold 16 Celldex Therapeutics shares in Q2 2016, an estimated $1K.
  • BlackRock Japan first reported a position in Celldex Therapeutics in Q1 2014 and held it in 8 quarters.
  • BlackRock Japan's Celldex Therapeutics position peaked at $37K in Q1 2014.
  • 141 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q2 2016.

Based on BlackRock Japan's 13F filing for Q2 2016, filed 10 Aug 2016.